Foundation Medicine, Inc. (FMI) Extends And Expands Collaboration To Provide Molecular Information And Genomic Profiling For Clinical Oncology Programs
1/7/2014 9:10:23 AM
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Foundation Medicine today announced it has extended and expanded its ongoing collaboration with Novartis to provide molecular information and comprehensive genomic profiling analysis in support of many of Novartis’ clinical oncology programs. The collaboration will now extend through at least September 2016.
Help employers find you! Check out all the jobs and post your resume.
comments powered by